m |
m |
||
Line 28: | Line 28: | ||
− | <font size=5>[[Design sequence flow chart# | + | <font size=5>[[Design sequence flow chart#Does the project create one acre or more of new and/or fully reconstructed impervious surfaces?|Begin Flow chart]]</font size> |
− | == | + | ===Does the project create one acre or more of new and/or fully reconstructed impervious surfaces=== |
− | Does the project create one acre or more of new and/or fully reconstructed impervious surfaces | ||
*[[Design sequence flow chart#Goal does not apply|No]] | *[[Design sequence flow chart#Goal does not apply|No]] | ||
*[[Design sequence flow chart#Linear project|Yes]] | *[[Design sequence flow chart#Linear project|Yes]] | ||
Line 38: | Line 37: | ||
___________________________________________________________ | ___________________________________________________________ | ||
− | |||
− | |||
− | |||
− | |||
===DWSMA=== | ===DWSMA=== | ||
Is the site located in a DWSMA, wellhead protection area, or near a drinking well? | Is the site located in a DWSMA, wellhead protection area, or near a drinking well? | ||
Line 90: | Line 85: | ||
===Karst, shallow groundwater, shallow bedrock=== | ===Karst, shallow groundwater, shallow bedrock=== | ||
+ | |||
+ | ===The MIDS performance goal does not apply=== |
This is intended to take you through a design sequence that allows you to determine the appropriate performance goal at a site. Follow the questions below sequentially to arrive at a performance goal appropriate for your site.
___________________________________________________________
Is the site located in a DWSMA, wellhead protection area, or near a drinking well?
Are there existing or proposed utilities, structures, or land use requirements (density, parking, setbacks, etc.) that make the Treatment Goal infeasible or cost prohibitive?
Is BMP relocation possible?
Are Flexible Treatment Option Alternatives number 1 or number 2 feasible?
Investigate Off-Site Considerations:
Provide site survey, maps, regulations, and/or cost estimates documenting infeasibility and cost-prohibitive nature of meeting the original Treatment Goal or FTO Alternatives
END